Pharmabiz

Hemostemix receives US FDA support for its basket protocol approach

Hemostemix receives US FDA support for its basket protocol approach: Calgary, Alberta Tuesday, January 20, 2026, 18:00 Hrs [IST] Hemostemix Inc., the leading autologous stem cell ...
Pharmabiz

Daiichi Sankyo receives Prime Minister’s Award for Japan Medical Research and Development Grand Prize

Daiichi Sankyo receives Prime Minister’s Award for Japan Medical Research and Development Grand Prize: Tokyo Tuesday, January 20, 2026, 17:00 Hrs [IST] Daiichi Sankyo has receiv ...
Pharmabiz

Experts unite to strengthen awareness and advanced care for multiple sclerosis

Experts unite to strengthen awareness and advanced care for multiple sclerosis: Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:50 Hrs [IST] Multiple Sclerosis Society of Indi ...
Pharmabiz

GSK to acquire California-based biopharma company, RAPT Therapeutics for $2.2 billion

GSK to acquire California-based biopharma company, RAPT Therapeutics for $2.2 billion: London, UK Tuesday, January 20, 2026, 16:45 Hrs [IST] GSK plc announced that it has entered ...
Pharmabiz

HRV Pharma and Haleos Labs inks CDMO alliance to fast-track orphan drug & niche API development

Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:30 Hrs [IST] ...
Pharmabiz

Dentalkart inks pact with NSK Japan to strengthen access to authentic dental technology in India

Dentalkart inks pact with NSK Japan to strengthen access to authentic dental technology in India: Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:15 Hrs [IST] Dentalkart, Indi ...
Pharmabiz

iRegene's NouvNeu001 receives US FDA Regenerative Medicine Advanced Therapy designation to treat Parkinson's disease

NouvNeu004: Recently received I-III all-stage IND approval from the NMPA, making it the world's first cell therapy product for Multiple System Atrophy (MSA) and iRegene's third self-developed product ...
Pharmabiz

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035: Our Bureau, Bengaluru Tuesday, January 20, 2026, 15:40 Hrs [IST] Syngene Inter ...
Pharmabiz

Onyx Scientific expands material science capabilities as part of 25th anniversary milestone

Onyx Scientific expands material science capabilities as part of 25th anniversary milestone: Our Bureau, Mumbai Tuesday, January 20, 2026, 15:00 Hrs [IST] Onyx Scientific, a CDMO ...
Pharmabiz

UK MHRA statement on new review of paracetamol safety during pregnancy

The MHRA regularly reviews the safety of paracetamol during pregnancy to ensure that the benefits to the patient and unborn baby outweigh any risks. Patients should not stop taking their pain ...
Pharmabiz

Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin

Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin: London Tuesday, January 20, 2026, 13:00 Hrs [IST] A m ...
Pharmabiz

AbelZeta announces AstraZeneca agreed to acquire AbelZeta’s 50% share of China development and commercialization rights to C-CAR031

AbelZeta announces AstraZeneca agreed to acquire AbelZeta’s 50% share of China development and commercialization rights to C-CAR031: Rockville, Maryland Tuesday, January 20, 202 ...